Detrimental effects of papaverine on the human internal thoracic artery

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 1, 2003, Pages 179-185

  Gao, Yu Jing ^a   Yang, Homer ^a   Teoh, Kevin ^a   Lee, Robert M K W ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; PAPAVERINE; PHENYLEPHRINE; SODIUM CHLORIDE; VASODILATOR AGENT;

ACIDIFICATION; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD VESSEL FUNCTION; CELL FUNCTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

EID: 0041341984     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00040-0     Document Type: Article

References (30)

1. Kurlansky PA, Dorman MJ, Galbut DL, Moreno NL, Traad EA, Carrillo RG, et al. Bilateral internal mammary artery grafting in women: a 21-year experience. Ann Thorac Surg. 1996;62:63-9.
2. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary grafts. J Thorac Cardiovasc Surg. 1985;89:248-58.
3. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, et al. Influence of the internal mammary graft on 10 year survival and other cardiac events. N Engl J Med. 1986;314:1-6.
4. Ghali WA, Quan H, Brant R. Coronary artery bypass grafting in Canada: national and provincial mortality trends, 1992-1995. CMAJ. 1998;159:25-31.
5. Tu JV, Wu KY. The improving outcomes of coronary artery bypass graft surgery in Ontario, 1981 to 1995. CMAJ. 1998;159:221-7.
6. Sasson L, Cohen AJ, Hauptman E, Schachner A. Effect of topical vasodilators on internal mammary arteries. Ann Thorac Surg. 1995;59:494-6.
7. Downing SW, Edmunds LHJ. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 1992;54:1236-43 (see comments].
8. Vilandt J, Kjaergard H, Aggestrup S, Andreasen JJ, Olesen A. Intraluminal papaverine with pH 3 doubles blood flow in the internal mammary artery. Scand Cardiovasc J. 1999;33:330-2.
9. Dregelid E, Heldal K, Resch F, Stangeland L, Breivik K, Svendsen E. Dilation of the internal mammary artery by external and intraluminal papaverine application. J Thorac Cardiovasc Surg. 1995;110:697-703.
10. Rubens FD, Labow RS, Meek E, Bedard E, Gill IS, Dudani AK, et al. Papaverine solutions cause loss of viability of endothelial cells. J Cardiovasc Surg (Torino). 1998;39:193-9.
11. Yoshimura S, Hashimoto N, Goto Y, Sampei K, Tsukahara T, Iihara K. Intraarterial infusion of high-concentration papaverine damages cerebral arteries in rats. Am J Neuroradiol. 1996;17:1891-4.
12. Schyvens CG, Owe-Young RA, Spratt PM, Mundy JA, Farnsworth AE, Macdonald PS. Papaverine abolishes endothelium-dependent dilatation of human internal mammary arteries in vitro. Clin Exp Pharmacol Physiol. 1997;24(3-4):223-8.
13. Cooper GJ, Gillot T, Parry EA, Kennedy A, Wilkinson GA. Papaverine injures the endothelium of the internal mammary artery. Cardiovasc Surg. 1995;3:553-5.
14. Gao YJ, Stead S, Lee RMKW. Papaverine induces apoptosis in vascular endothelial and smooth muscle cells. Life Sci. 2002;70:2675-85.
15. Dickhout JG, Lee RM. Apoptosis in the muscular arteries from young spontaneously hypertensive rats. J Hypertens. 1999;17:1413-9.
16. Dickhout JG, Lee RMKW. Increased medial smooth muscle cell length is responsible for vascular hypertrophy in young hypertensive rats. Am J Physiol. 2000;279:H2085-94.
17. Hillier C, Watt PA, Spyt TJ, Thurston H. Contraction and relaxation of human internal mammary artery after intraluminal administration of papaverine. Ann Thorac Surg. 1992;53:1033-7.
18. He G-W. Verapamil plus nitroglycerin solution maximally preserves endothelial function of the radial artery: comparison with papaverine solution. J Thorac Cardiovasc Surg. 1998;115:1321-7.
19. Leblebicioglu B, Walters J. Alkaline conditions accelerate polymorphonuclear leukocyte apoptosis in vitro. Infect Immun. 1999;67:2019-21.
20. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implication of multiple isoforms. Physiol Rev. 1995;75:725-47.
21. Leszczynski D, Zhao Y, Luokkamaki M, Foegh ML. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol. 1994;145:1265-70.
22. Hamet P, Richard L, Dam TV, Teiger E, Orlov SN, Gaboury L, et al. Apoptosis in target organ of hypertension. Hypertension. 1995;26:642-8.
23. 45Ca ion in subcellular fractions of dog biliary muscles. Biochem Pharmacol. 1984;33:281-6.
24. Martikainen P, Isaacs J. Role of calcium in the programmed death of rat prostatic glandular cells. Prostate. 1990;17:175-87.
25. Morikawa N, Nakagawa-Hattori Y, Mizuno Y, Effects of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex I activity. J Neurochem. 1996;66:1174-81.
26. Chester AH, Panda R, Borland JAA, Tadjkarimi S, Schyns CJ, O'Neil GS, et al. Effects of mode of application of papaverine on the contractile response of the internal mammary artery. Br J Surg. 1994;81:527-31.
27. Chamiot-Clerc P, Renaud JF, Safar ME. Pulse pressure, aortic activity, and endothelium dysfunction in old hypertensive rats. Hypertension. 2001;37:313-21.
28. Karlsson C, Bodelsson G, Bodelsson M, Stjemquist M. Endothelium-derived prostanoids reduce 5-hydroxytryptamine-induced contraction in human uterine artery. Hum Reprod. 1998;13:1947-51.
29. Milligan CE, Schwartz LM. Programmed cell death during animal development. Br Med Bull. 1997;53:570-90.
30. Walia M, Sormaz L, Samson SE, Lee RM, Grover AK. Effects of hydrogen peroxide on pig coronary artery endothelium. Eur J Pharmacol. 2000;400(2-3):249-53.